Cigna Group (NYSE:CI) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Cigna Group (NYSE:CI) have been assigned an average recommendation of “Moderate Buy” from the twenty-four ratings firms that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have given a hold recommendation, nineteen have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $331.8261.

Several analysts have recently commented on the stock. Guggenheim reiterated a “buy” rating and issued a $318.00 target price on shares of Cigna Group in a report on Tuesday, December 2nd. Sanford C. Bernstein reduced their price objective on shares of Cigna Group from $346.00 to $294.00 and set a “market perform” rating for the company in a research report on Wednesday, November 12th. Zacks Research cut shares of Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. JPMorgan Chase & Co. cut their target price on Cigna Group from $428.00 to $375.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 4th. Finally, Cantor Fitzgerald reduced their target price on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st.

Insider Activity at Cigna Group

In related news, CEO David Cordani purchased 4,134 shares of the business’s stock in a transaction that occurred on Monday, November 3rd. The shares were bought at an average cost of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This represents a 2.69% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.70% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CI. Pathway Financial Advisers LLC lifted its position in shares of Cigna Group by 2.3% during the 2nd quarter. Pathway Financial Advisers LLC now owns 1,501 shares of the health services provider’s stock valued at $496,000 after buying an additional 34 shares in the last quarter. Armstrong Advisory Group Inc. raised its stake in Cigna Group by 17.7% during the 3rd quarter. Armstrong Advisory Group Inc. now owns 226 shares of the health services provider’s stock worth $65,000 after acquiring an additional 34 shares during the period. Central Pacific Bank Trust Division lifted its holdings in Cigna Group by 1.0% during the second quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after purchasing an additional 35 shares in the last quarter. HM Payson & Co. boosted its position in shares of Cigna Group by 0.9% in the third quarter. HM Payson & Co. now owns 3,785 shares of the health services provider’s stock worth $1,091,000 after purchasing an additional 35 shares during the period. Finally, Carr Financial Group Corp increased its stake in shares of Cigna Group by 5.3% in the third quarter. Carr Financial Group Corp now owns 709 shares of the health services provider’s stock worth $204,000 after purchasing an additional 36 shares in the last quarter. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $278.95 on Monday. Cigna Group has a 52 week low of $239.51 and a 52 week high of $350.00. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The business has a 50 day moving average price of $272.29 and a 200-day moving average price of $290.25. The company has a market cap of $74.52 billion, a PE ratio of 12.30, a price-to-earnings-growth ratio of 0.97 and a beta of 0.26.

Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The business had revenue of $69.57 billion during the quarter, compared to the consensus estimate of $66.40 billion. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.Cigna Group’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.51 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were paid a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.2%. The ex-dividend date was Thursday, December 4th. Cigna Group’s dividend payout ratio is 26.64%.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.